Assembly Biosciences Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | +64.1% | +7.8% | +395.6% | -92.1% | -100.0% | – | +298.2% | +153.5% | |
| – | -99.7% | +23.5% | +55,008.3% | +64.5% | +17.9% | +18.2% | -99.5% | +6.9% | +9,719.3% | +14.4% | -99.8% | |
| – | – | – | – | – | – | -239.3% | – | -108.0% | – | – | – | |
| – | +71.3% | +80.3% | +33.6% | +64.5% | +17.9% | +24.6% | -35.9% | +2.1% | -30.1% | +14.4% | +15.9% | |
| – | -14.7% | +7.9% | +39.7% | +104.4% | -5.4% | +12.0% | -21.9% | -16.1% | -5.1% | -21.4% | +8.9% | |
| – | +23.8% | +52.7% | +35.3% | +75.6% | +10.4% | -64.2% | +226.6% | -32.3% | -75.7% | -21.4% | +368.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -45.3% | +3,044.4% | -99.4% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -170.4% | – | – | – | – | +900.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.